Stable and functional human intestinal epithelium derived from induced pluripotent stem cells

Area of Science:

• Stem cell biology
• Drug discovery and development
• Gastroenterology

Background:

• Caco-2 cells are a standard model for intestinal drug absorption but exhibit limited drug metabolism, leading to physiological discrepancies.
• There is a need for more accurate in vitro models that better recapitulate human intestinal function for drug development.

Purpose of the Study:

• To evaluate human intestinal epithelial cells derived from pluripotent stem cell-derived organoids as an alternative to Caco-2 cells.
• To assess the morphology, gene expression, barrier function, transporter activity, drug metabolism, and cytotoxicity of these novel cells.
• To determine the scalability and stability of these cells for use in drug discovery.

Main Methods:

• Generation of human intestinal epithelial cells from pluripotent stem cell-derived organoids.
• Expansion of cells in 2D culture.
• Assessment of cell morphology, gene expression, barrier integrity (e.g., transepithelial electrical resistance).
• Evaluation of drug transporter activity (e.g., peptide transport) and drug-metabolizing enzyme activity (e.g., CYP3A4).
• Cytotoxicity assays and stability assessment over multiple passages.

Main Results:

• Human intestinal epithelial cells derived from pluripotent stem cells can be efficiently expanded in 2D culture, yielding homogeneous, high-performance cells.
• These cells retain key small intestine functions, including high CYP3A4 activity and efficient peptide transport, over multiple passages.
• Barrier integrity, transporter activity, and drug metabolism remain stable across passages, indicating robust physiological relevance.

Conclusions:

• Human pluripotent stem cell-derived intestinal epithelial cells represent a promising, scalable, and physiologically relevant alternative to Caco-2 cells for drug discovery.
• These cells maintain critical small intestine functions, making them suitable for advanced in vitro models, including microphysiological systems and organ-on-chip technologies.
• Their use can improve the accuracy of drug absorption, metabolism, and toxicity studies, ultimately aiding in the development of safer and more effective therapeutics.